SWM
BNGO icon

Spire Wealth Management’s Bionano Genomics BNGO Stock Holding History

Spire Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3
Closed -$1.17K – 2370
2023
Q2 		$1.17K Hold
3
– – ﹤0.01% 2289
2023
Q1 		$2.13K Hold
3
– – ﹤0.01% 2249
2022
Q4 		$3K Hold
3
– – ﹤0.01% 1945
2022
Q3 		$3K Sell
3
-107
-97% -$141K ﹤0.01% 1848
2022
Q2 		$91K Buy
110
+17
+18% +$17.5K ﹤0.01% 1068
2022
Q1 		$145K Sell
93
-7
-7% -$9.45K ﹤0.01% 1030
2021
Q4 		$180K Buy
100
+75
+300% +$201K ﹤0.01% 1138
2021
Q3 		$84K Hold
25
– – ﹤0.01% 1251
2021
Q2 		$112K Sell
25
-13
-34% -$51.3K ﹤0.01% 1153
2021
Q1 		$179K Buy
+38
New +$214K ﹤0.01% 1118

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Spire Wealth Management's BNGO Position: Q3 2023 in Review

Spire Wealth Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 3 shares — an estimated $1.17K sold.

Spire Wealth Management first reported a position in BNGO in Q1 2021 and held it in 10 quarters. The position peaked at $180K in Q4 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Spire Wealth Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Spire Wealth Management sold 3 Bionano Genomics shares in Q3 2023, an estimated $1.17K.
  • Spire Wealth Management first reported a position in Bionano Genomics in Q1 2021 and held it in 10 quarters.
  • Spire Wealth Management's Bionano Genomics position peaked at $180K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Spire Wealth Management's 13F filing for Q3 2023, filed 8 Nov 2023.